GHK-Cu
GHK-Cu

Price range: £19.99 through £29.99

Add to basket This product has multiple variants. The options may be chosen on the product page

GHK-Cu

Price range: £19.99 through £29.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

GHK-Cu is a copper-binding tripeptide complex supplied as a lyophilised material for extracellular-matrix and tissue-remodelling research.

GHK-Cu
This item: GHK-Cu
Price range: £19.99 through £29.99
Price range: £19.99 through £29.99
Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
MOTS-c - 10mg
MOTS-c - 10mg

In stock

£24.99
1 Vial
£19.99
1 Vial
£17.99 Save 10%
3 Vials
£16.99 Save 15%
5 Vials
£15.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

GHK-Cu is a copper-binding complex of the tripeptide glycyl-L-histidyl-L-lysine. It is studied in laboratory models of collagen synthesis, extracellular-matrix regulation and tissue remodelling, and is supplied as a lyophilised research material.

Research material only

This material is not supplied as a medicine, treatment, cosmetic, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

CompoundGHK-Cu
Alternative nameCopper tripeptide-1
Research classCopper-binding tripeptide complex
Reference molecular massApproximately 400.9 Da (complex form-dependent)
FormLyophilised material

Research context

GHK is the tripeptide glycyl-L-histidyl-L-lysine and forms a coordination complex with copper(II). Published studies have investigated GHK-Cu in fibroblast and tissue-remodelling models, including work concerning collagen synthesis, glycosaminoglycan production and extracellular-matrix accumulation. References to published studies describe the materials and experimental conditions used by those authors; they do not establish the identity, performance or suitability of any material sold on this page.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the vial size and batch identifier to the corresponding report before relying on any result.

View available GHK-Cu lab results →

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Keep the sealed lyophilised vial dry and protected from direct light.
  • A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, compound-specific information and your laboratory’s validated procedure.
  • Use clean laboratory technique and equipment appropriate to the intended analytical method.
  • Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
  • Avoid repeated temperature cycling and unnecessary exposure to moisture.

Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.

Frequently asked questions

What is GHK-Cu?

GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. It is also commonly referred to as copper tripeptide-1.

Is this GHK-Cu supplied as a medicine or cosmetic?

No. This material is supplied solely for controlled laboratory research. It is not supplied as a medicine, treatment, cosmetic, supplement or consumer product.

Which vial sizes are available?

Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.

Does every vial size have a published laboratory result?

No. Results are available only for the selected batches and vial sizes marked with a result indicator. Always check the batch identifier on the report.

How should the material be stored?

Keep the sealed lyophilised material dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, compound-specific information and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.

Information reviewed: 29 August 2026.

Size

50mg, 100mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published research

The sources below concern GHK-Cu (the glycyl-L-histidyl-L-lysine copper complex) as investigated by their respective authors. They are provided for scientific context and do not establish the identity, purity, performance or suitability of any material sold on this page.

  1. Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 1988. View on PubMed ↗
  2. Maquart FX et al. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences, 1992. View on PubMed ↗
  3. Maquart FX et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation, 1993. View on PubMed ↗
  4. PubChem. Copper tripeptide compound record CID 139035031, containing reference identifiers and structural information. View compound record ↗

Literature is not batch evidence

Published findings relate to the materials and conditions used by the cited researchers. Assess any available batch documentation separately.